Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.03 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced outside the brain (t-cells) | 0.10 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | 7 Parkinson's trials, 1 stopped | 0.89 |
| literature PubMed | 43 Parkinson's papers of 23,713 | 0.50 |
| pathways Reactome | 2 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 6720
Sealed predictions
- FOXP3 in dopamine neurons, braak-0.51 (p 0.163) → +0.09 (p 0.825)receipt 6727
Swarm cases
receipt 6727: FOXP3 in dopamine neurons, braak
- power
- full sample -0.34 (p 0.173, n 18), 95% CI -0.69 to +0.16. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.38 (p 0.116, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.56 (p 0.016, n 18). not the mix.
- skeptic
- leave-one-out range -0.43 to -0.25, sign flips 0; without severely affected donors -0.34 (p 0.173, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FOXP3 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts